Form 4: Stryker Group President's Routine Stock Transactions

Stryker Group President James Andrew Pierce reported the vesting of performance stock units and related stock transactions, including the acquisition of dividend equivalents and disposition for tax purposes.

Summary

• James Andrew Pierce, Group President of Stryker Corp (SYK), reported transactions on March 21, 2026.
• Acquired 430 shares of Common Stock at a price of $0, representing dividend equivalents from previously earned Performance Stock Units.
• Disposed of 7,807 shares of Common Stock at $335.67 per share, likely for tax withholding purposes.
• Following these transactions, Pierce directly owns 80,869 shares of Common Stock.
• Indirect holdings include 712 shares by Son GP, 713 shares by Son AP, and 1,595 shares by 401K.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it reflects the successful vesting of performance-based awards, indicating the achievement of prior performance criteria, despite the routine tax-related sale.

Positives

• The acquisition of 430 shares at $0 represents dividend equivalents, indicating a benefit from previously earned performance stock units.
• The vesting of Performance Stock Units (14,912 shares mentioned in the explanation) indicates the satisfaction of performance criteria.

Negatives

• Disposition of 7,807 shares of Common Stock at $335.67, likely for tax obligations, reduces direct beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported on Form 4, provide transparency into executive compensation and ownership, which can be a signal of management's confidence in the company's future, though these specific transactions are routine vesting and tax-related.

Comparison to Industry Standards

• These transactions are standard for executive compensation plans involving performance stock units and tax withholding upon vesting.
• Comparable companies in the medical technology sector, such as Medtronic (MDT) or Johnson & Johnson (JNJ), often have similar executive equity compensation structures where shares vest and a portion is sold to cover tax liabilities.

Stakeholder Impact

• Shareholders: Minor dilution from the issuance of shares (dividend equivalents) but overall a routine compensation event.
• Management: James Andrew Pierce's direct ownership slightly decreased due to tax-related sales, but overall compensation structure is functioning as intended.

Key Dates

Recommendation

This Form 4 details routine executive compensation events, specifically the vesting of performance stock units and subsequent tax-related share dispositions. It does not provide new fundamental information about Stryker's operational performance or strategic direction that would warrant a change in investment recommendation. The transactions are expected and reflect the normal course of executive equity awards.

Keywords

Stryker, SYK, Form 4, Insider Trading, Stock Transaction, Performance Stock Units, Dividend Equivalents, Executive Compensation